Abstract
No public abstract is available from the verified source records.
Xiaonan Ma, Ying Wei, Chunyan Lan, Binong Su, Rongmeng Tian, Zhiyuan Lv, Aihua Hu, Huafang Gao
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Human plasma lipoprotein[a] structural properties
10.1016/s0021-9258(18)32663-2 · 1983
Protein-composition of Lp(a) lipoprotein from human-plasma
10.1016/0014-5793(83)80182-3 · 1983
Relationship between apolipoprotein(a) isoforms and lipoprotein(a) levels in patients with acute coronary syndrome
2026
Ancestral variation in lp(a): Epidemiology, isoform diversity, and testing
10.1007/s11883-025-01365-0 · 2025
Lp(a) concentration and apo(a) isoform size - relation to the presence of coronary-artery disease in familial hypercholesterolemia
10.1161/01.atv.14.10.1561 · 1994
Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a)
10.1253/jcj.63.659 · 1999
Low molecular weight apolipoprotein(a) phenotype rather than lipoprotein(a) is associated with coronary atherosclerosis and myocardial infarction
10.3389/fcvm.2022.843602 · 2022
Small apolipoprotein(a) isoforms may predict primary patency following peripheral arterial revascularization
2024
Apolipoprotein(a) isoforms and the risk of vascular disease systematic review of 40 studies involving 58,000 participants
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
10.1016/j.jacc.2009.10.080 · 2010
Global, regional and national burden of ischemic heart disease and its attributable risk factors from 1990 to 2021: A systematic analysis of the global burden of disease study 2021
10.1186/s12872-025-05022-x · 2025
Association between lipoprotein(a) levels, apo(a) isoforms and family history of premature cad in young asian indians
10.1016/j.clinbiochem.2008.01.016 · 2008
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study (vol 364, pg 937m 2004)
10.1016/s0140-6736(04)17018-9 · 2004
Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): Case-control study
10.1016/s0140-6736(04)17019-0 · 2004
Potentially modifiable risk factors associated with myocardial infarction in China: The INTERHEART China study
10.1136/hrt.2008.155796 · 2009
Lipoprotein(a) levels and the risk of myocardial infarction among 7 ethnic groups
10.1161/circulationaha.118.034311 · 2019
Rubiés-Prat J. Differential expression of double-band apolipoprotein(a) phenotypes in healthy Spanish subjects detected by SDS-agarose immunoblotting
10.1016/s0009-8981(98)00126-0 · 1998
Thematic review series: Lipoprotein: Coming of age at last structure, function, and genetics of lipoprotein
10.1194/jlr.r067314 · 2016
Lipoprotein(a) beyond the kringle iv repeat polymorphism: The complexity of genetic variation in the LPA gene
10.1016/j.atherosclerosis.2022.04.003 · 2022
The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity
10.1097/mol.0b013e328308b622 · 2008
Determinants of binding of oxidized phospholipids on apolipoprotein and lipoprotein
10.1194/jlr.m040733 · 2013
Oxidized phospholipids in cardiovascular disease
10.1038/s41569-023-00937-4 · 2024
Determination of kinetic-parameters of apolipoprotein-B metabolism using amino-acids labeled with stable isotopes
10.1016/s0022-2275(20)41961-3 · 1991
Plasma lipoprotein(a) concentration is controlled by apolipoprotein(a) (apo(a)) protein size and the abundance of hepatic apo(a) messenger-rna in a cynomolgus monkey model
10.1016/s0021-9258(18)92782-1 · 1991
Detection and quantitation of apolipoprotein(a) messenger-rna in human liver and its relationship with plasma lipoprotein(a) concentration
10.1016/0021-9150(91)90187-8 · 1991
Lp(a) assembly and the influence of allelic variation on apo(a) secretion
1992
Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner
10.1161/01.atv.0000021144.87870.c8 · 2002
Lipoprotein(a), oxidized phospholipids, and coronary artery disease severity and outcomes
10.1016/j.jacc.2023.02.050 · 2023
Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors results from the dallas heart study
10.1161/circulationaha.108.836940 · 2009
Oxidized phospholipid dynamics in the early post-infarction period: Effects of pcsk9 inhibition with evolocumab
10.1016/j.atherosclerosis.2025.120469 · 2025
Oxidized phospholipids on lipoprotein(a) elicit arterial wall inflammation and an inflammatory monocyte response in humans
10.1161/circulationaha.116.020838 · 2016
No additional external references are available.